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1164 Abstracts October 2013challenges included large aneurysm with displacement of overlying nerves
and extension of the aneurysm to the skull base. The repair was conducted
in conjunction with the otorhinolaryngology service. Somatory sensory
evoked potentials, a nerve-monitoring-enabled endotracheal tube and facial
nerve monitoring were performed. Via a transverse incision, the digastric
muscle was divided and the stylomandibular ligament released. This
permitted mobilization of the mandible and exposure of the ICA in the
infratemporal fossa. The hypoglossal, vagus, and ansa cervicalis were iden-
tiﬁed and preserved. The aneurysm sac was resected and the ICA was
repaired with 6-mm polytetraﬂuoroethylene interposition graft.
Results: The patient had an uneventful postoperative course. He
suffered no neurologic deﬁcits and was discharged home subsequently.
He has remained clinically stable for 10 months, although he has been non-
compliant with follow-up imaging.
Conclusions: Neuroﬁbromatosis type 1 is a neurocutaneous disorder
with multiorgan involvement. Vascular abnormalities are a very rare mani-
festation of this multisystem disorder and mostly involve the intracranial
circulation. We describe a successful repair of a large isolated ICA aneurysm.
Carotid Endarterectomy under Local Anesthesia Has Less Risk of
Myocardial Infarction Compared with General Anesthesia: An
Analysis of National Surgical Quality Improvement Program Database
Elias Kfoury, Jonathan Dort, Amber Trickey, Moira Crosby, Dipankar
Mukherjee. Inova Fairfax Hospital, Falls Churrch, VaTable. Comparison of 30-day postoperative myocardial infarction (MI), stroke,
anesthesia (LA) vs general anesthesia (GA) with and without adjustment for con
CEA under
LA n ¼ 4763
CEA under
GA n ¼ 37,502
Unadjusted
OR (95% C
MI, n (%) 20 (0.40) 323 (0.86) 0.49 (0.31,
Stroke, n (%) 66 (1.39) 592 (1.58) 0.88 (0.68,
Death, n (%) 32 (0.67) 315 (0.84) 0.80 (0.55,Objectives: As carotid endarterectomy (CEA) is being increasingly
compared with carotid artery stenting and the best current medical manage-
ment, it has become important to revisit variables that might affect the
outcomes of the procedure. Multiple studies have evaluated the effect of
anesthesia type on CEA with inconsistent results. Our study compared
30-day postoperative myocardial infarction (MI), stroke and mortality
between CEA under local or regional anesthesia (LA) and CEA under
general anesthesia (GA) utilizing National Surgical Quality Improvement
Program database.
Methods: All patients listed in National Surgical Quality Improve-
ment Program database that underwent CEA under GA and LA from
2005-2011 were included with the exception of patients undergoing simul-
taneous CEA and CABG. Postoperative MI, stroke, and death at 30 days
were compared between the two groups using simple and multiple logistic
regression.
Results: A total of 42,265 CEA cases were included. Thirty-seven
thousand ﬁve-hundred and two cases (88.7%) were performed under GA
and 4763 (11.3%) under LA. CEA under LA had a signiﬁcantly decreased
risk of 30 day postoperative MI when compared with CEA under GA
(0.4% vs 0.86%, P ¼ .012). No statistically signiﬁcant differences were found
in postoperative stroke or mortality (Table).
Conclusions: CEA under LA carries a decreased risk of postoperative
MI when compared with CEA under GA. Patients with multiple comorbid-
ities at risk of postoperative MI should be considered for CEA under LA.
Prospective Randomized Trial Acuseal vs Vascu-Guard Patching for
Carotid Endarterectomy
Patrick A. Stone, Ali AbuRahma, Stephen Hass, David Phang, Albeir
Mousa, Asmita Modak, Daniel Dearing. West Virginia University,
Charleston, WV
Objectives: Patch angioplasty with polytetraﬂuoroethylene, ACU-
SEAL (W. L. Gore & Associates, Flagstaff, Ariz), although prone to longer
hemostasis times, has been shown to have comparable results to patch
angioplasty with autogenous saphenous vein and polyester. This study
examined the short- and midterm clinical outcomes associated with carotid
endarterectomy using ACUSEAL patching vs Bovine pericardium, Vascu-
Guard, (Synovis Life Technologies, Inc, Biovascular Inc, Saint Paul,
Minn) patching. No prospective study has compared these two patches
previously.
Methods: The study prospectively randomized 200 patients (1:1)
undergoing carotid endarterectomy to either ACUSEAL or Vascu-Guard
patching. Demographic data was collected including risk factors, pertinent
laboratory parameters. Intraoperative hemostasis times were recorded in
both groups as well as frequency of re-exploration for neck hematoma.
All patients received 1-month duplex ultrasound and repeated at 6-month
intervals. Kaplan-Meier analysis was used to estimate the risk of restenosis
and stroke free survival rate in both patch groups.
Results: Demographics was similar between groups except for
higher incidence of current smokers and more patients with congestive
heart failure (P ¼ .02 and .03), respectively, in the ACUSEAL group.
Mean operative internal carotid artery diameter, and mean arteriotomy
length were similar in both groups. The mean hemostasis time was 4.90
minutes for ACUSEAL patching vs 3.09 minutes for Vascu-Guard (P ¼
.027); however, the mean operative times were similar for both groups
(ACUSEAL 2.09 hours vs Vascu-Guard 2.16 hours, P ¼ .067). However
the incidence of re-exploration for neck hematoma was higher in the
Vascu-Guard group 5.1% vs 0% (P ¼ .059). The incidence of perioperative
ipsilateral neurologic events was 3.1% for ACUSEAL patching vs 1% for
Vascu-Guard patching (P ¼ .368). The mean follow-up period is 11
months. The respective freedom from $70% carotid restenosis at 1, 2,
and 3 years was 100%, 100%, and 100% for ACUSEAL patching vs
100%, 100%, and 75% for Vascu-Guard patching (P ¼ .12). The stroke
free survival rate at 1, 2, and 3 years is 95% for ACUSEAL and 98.7%
for Vascu-Guard patching.and death for carotid endarterectomy (CEA) under local or regional
founding factors
I)
Unadjusted
P value Adjusted OR (95% CI)
Adjusted
P value
0.76) .002 0.55 (0.34, 0.87) .012
1.13) .318 0.92 (0.71, 1.20) .540
1.15) .227 0.92 (0.63, 1.34) .664
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ACUSEAL vs Vascu-Guard differed in hemostasis time the frequency of
re-exploration for neck hematomas were higher in the Vascu-Guard group.
Carotid endarterectomy with ACUSEAL patching and Vascu-Guard patch-
ing did not displayed any signiﬁcance differences between perioperative
neurologic events and late restenosis.
Clinical Trials.gov ID: NCT01184183
Despite Advances and Incorporation of Endovascular Techniques,
Mortality Rates for Patients with Acute Mesenteric Ischemia Remain
Unchanged: Analysis of the Nationwide Inpatient Sample
Mohammad H. Eslamia, Denis Rybinb, Gheorghe Dorosb, James T.
McPheea, Alik Farbera. aBoston University School of Medicine, Boston,
Mass; bBoston University School of Public Health, Boston, Mass
Objectives: Adoption and advances in endovascular surgery have
improved outcomes of vascular emergencies. We evaluated whether similar
trends apply to the treatment of acute mesenteric ischemia (AMI) using
a large inpatient database.
Methods: The Nationwide Inpatient Sample (2003-2010) was
queried using International Classiﬁcation of Diseases, Ninth Revision
code for AMI (557.1). Patients who had any open vascular or endovascular
procedures were selected. This cohort was divided into the open vascular
group (OVG) and endovascular group (EVG) based on the International
Classiﬁcation of Diseases, Ninth Revision procedure codes for primary
and secondary procedures. Bivariate analyses were performed using c2
test, t-test, and gamma regression when appropriate. Logistic regression
was used to determine factors affecting mortality while adjusting for con-
founding variables.
Results: We identiﬁed 6683 patients of which majority had an
endovascular procedure (4187, 62.7% vs 2496, 37.3%; P < .001) with
an overall in-hospital mortality rate (IHM) of 17.4%. Age, race, and
sex were similar across groups EVG had a signiﬁcantly higher Elixhauser
comorbidities index (3 6 1.6 vs 2.76 1.5; P ¼ .007) and a signiﬁcantly
higher rate of peripheral vascular disease than OVG (44.5% vs 29.2%;
P < .001). Despite this, EVG had signiﬁcantly lower in-hospitalmortality (IHM) rates (15.3% vs 21.2%, P ¼ .006), median charges
($72,907 vs $101,762; P < .001), and length of stay (9 vs 14 days;
P < .001) (Fig). Over the 8-year period of study, there was no change
in the overall mortality rate among EVG or OVG groups. Factors
affecting mortality rate included age (OR, 1.03; 95% CI, 1.02-1.04; P <
.001) and open surgery (OR, 1.45; CI, 1.07-1.96; P ¼ .016). Presence
of peripheral vascular disease correlated with decreased overall mortality
(OR, 0.60; CI, 0.43-0.85; P ¼ .004).
Conclusions: Despite incorporation of more advanced endovascular
therapies, the mortality rate for AMI remains unchanged throughout the
study period. Type of surgery and age are the most signiﬁcant factors
affecting mortality with EVG patients having better survival despite higher
morbidity indices.
Fig.
